Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Skinbiotherap. (SBTX) Share Price

Price 16.25p on 25-07-2025 at 18:50:07
Change -0.125p -0.76%
Buy 16.50p
Sell 16.00p
Last Trade: Buy 30,000.00 at 16.338p
Day's Volume: 1,040,031
Last Close: 16.25p
Open: 16.25p
ISIN: GB00BF33H870
Day's Range 16.25p - 16.375p
52wk Range: 10.25p - 27.50p
Market Capitalisation: £42.05m
VWAP: 16.41095p
Shares in Issue: 258.78m

Skinbiotherap. (SBTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 30,000 16.338p Ordinary
16:27:26 - 25-Jul-25
Buy* 35,159 16.50p Suspected BUY Trade
16:09:31 - 25-Jul-25
Buy* 50,000 16.338p Ordinary
15:14:12 - 25-Jul-25
Buy* 15,000 16.338p Ordinary
15:09:47 - 25-Jul-25
Unknown* 200,000 16.50p Ordinary
15:03:16 - 25-Jul-25
Unknown* 400,000 16.50p Negotiated Trade
15:03:03 - 25-Jul-25
Buy* 5,439 16.34p Ordinary
15:02:38 - 25-Jul-25
Sell* 1,358 16.111p Ordinary
14:33:06 - 25-Jul-25
Unknown* 35,159 16.355p Ordinary
14:14:13 - 25-Jul-25
Unknown* -35,159 16.50p Ordinary
Correction
14:14:12 - 25-Jul-25
See more Skinbiotherap. trades

Skinbiotherap. (SBTX) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jul 2025 (Fri) 16.25 16.375 16.25 16.25 1,040,031
24th Jul 2025 (Thu) 16.75 16.80 16.375 16.375 654,670
23rd Jul 2025 (Wed) 16.625 16.75 16.75 16.75 197,182
22nd Jul 2025 (Tue) 16.50 16.625 16.50 16.625 418,849
21st Jul 2025 (Mon) 16.50 16.50 16.50 16.50 977,282
18th Jul 2025 (Fri) 16.50 16.75 16.50 16.50 1,266,258
17th Jul 2025 (Thu) 16.50 16.50 16.50 16.50 892,464
16th Jul 2025 (Wed) 16.50 16.50 16.50 16.50 639,736
15th Jul 2025 (Tue) 16.25 16.50 16.25 16.50 674,695
14th Jul 2025 (Mon) 16.625 16.625 16.25 16.25 921,888
11th Jul 2025 (Fri) 16.75 16.75 16.50 16.625 833,237
10th Jul 2025 (Thu) 16.75 16.75 16.75 16.75 518,385
9th Jul 2025 (Wed) 16.75 16.80 16.75 16.75 950,002
8th Jul 2025 (Tue) 16.75 16.75 16.75 16.75 163,999
7th Jul 2025 (Mon) 16.625 16.75 16.625 16.75 2,870,493
4th Jul 2025 (Fri) 16.50 16.625 16.50 16.625 2,253,239
3rd Jul 2025 (Thu) 16.50 16.80 16.50 16.50 1,884,878
2nd Jul 2025 (Wed) 16.50 16.80 16.50 16.50 227,645
1st Jul 2025 (Tue) 16.50 16.50 16.50 16.50 666,998
30th Jun 2025 (Mon) 16.625 16.80 16.50 16.80 1,255,293
27th Jun 2025 (Fri) 16.625 16.80 16.50 16.80 1,260,075
26th Jun 2025 (Thu) 16.50 16.625 16.50 16.625 2,767,355
See more Skinbiotherap. price history

Skinbiotherap. (SBTX) Regulatory News

Date Source Headline
30th Jun 2025 7:00 am RNS Croda Commercial Launch Progressing as Expected
27th Jun 2025 7:00 am RNS Notice of IMC Shareholder Presentation
25th Jun 2025 11:28 am RNS Holding(s) in Company
20th Jun 2025 7:00 am RNS Result of WRAP Retail Offer
16th Jun 2025 2:02 pm RNS WRAP Retail Offer
16th Jun 2025 7:00 am RNS Superdrug agreement, Placing & Retail Offer
22nd May 2025 12:44 pm RNS Correction: Change of Adviser
22nd May 2025 7:00 am RNS Change of advisor
9th May 2025 2:39 pm RNS Holding(s) in Company
9th May 2025 2:30 pm RNS Holding(s) in Company
See more Skinbiotherap. regulatory news

Skinbiotherap. (SBTX) Share News

IN BRIEF: SkinBioTherapeutics raises GBP4 million for Superdrug deal

20th Jun 2025 13:18

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Raises GBP4.2 million from the sale of 24.7 million new shares at 17 pence each. This is split between 24.1 million shares sold via placing and subscription, and 587,191 sold in an offer to retail investors. SkinBioTherapeutics announced the equity raise on Monday, saying it is to support an exclusive commercial agreement with Superdrug Stores PLC to roll-out AxisBiotix food supplements across the UK. The supplements are meant to alleviate inflammatory skin conditions. Read More

TRADING UPDATES: SkinBioTherapeutics hails "milestone" Superdrug deal

16th Jun 2025 21:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: SkinBioTherapeutics boosts financial 2025 turnover forecast

23rd Oct 2024 16:34

SkinBioTherapeutics PLC - Newcastle, England-based skin health-focused life sciences company - Says the integration of its GBP1.3 million acquisition, Bio-Tech Solutions Ltd, is "well-advanced". It was the company's second acquisition this year, the first being Dermatonics, and the group now has sufficient cash runway to support its operations through to the summer of 2026 without any additional income from its Croda partnership or other joint development agreements. Before the acquisitions, the group projected financial 2024 turnover of around GBP250,000. It now forecasts annualised turnover of GBP6.3 million for financial 2025. Read More

AIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buys

11th Oct 2024 10:38

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

AIM WINNERS & LOSERS: SkinBioTherapeutics gets Croda positive feedback

19th Sep 2024 10:54

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

See more Skinbiotherap. news
FTSE 100 Latest
Value9,120.31
Change-18.06

Login to your account

Forgot Password?

Not Registered